awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q38285319-BC23615D-E13C-4F0A-994D-4E88E007D48D
Q38285319-BC23615D-E13C-4F0A-994D-4E88E007D48D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38285319-BC23615D-E13C-4F0A-994D-4E88E007D48D
Current choice of treatments for neovascular AMD.
P2860
Q38285319-BC23615D-E13C-4F0A-994D-4E88E007D48D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38285319-BC23615D-E13C-4F0A-994D-4E88E007D48D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
01f17be262731796c6c53e63274e11d713c19b90
P2860
Intraocular pharmacokinetics of ranibizumab following a single intravitreal injection in humans.